INSIGHT. Traditional medicine has long relied on three pillars: removing, repairing, or replacing damaged tissue. A fourth pillar is now emerging: regenerative medicine.
Rather than treating symptoms, regenerative medicine aims to restore the body’s function by stimulating its own healing capacity, potentially reducing the need for prosthetics, transplants, and long-term medication.
The field has progressed from research into clinical application, with a clear connection between technological advances and medical needs, particularly in biomaterials.
Limitations of current treatments
Surgery, transplants, and implants are well-established treatment methods, but they have limitations: donor tissue shortages, risk of complications, and the need for immunosuppressive therapy.
There is a clear gap between current solutions and patient needs. Regenerative medicine has emerged as a response to this, with the goal of developing more precise, locally acting treatments that work more closely with the body’s own processes.
From passive implants to bioactive materials
A key driver of this development is the shift towards bioactive materials. Traditional implants provide mechanical support but do not actively contribute to healing.
New biomaterials, such as calcium phosphate and bioactive glass, can mimic bone tissue and stimulate healing, and in some cases release drugs or growth factors directly into the damaged area, enabling more targeted treatment.
As technology advances, new possibilities are opening up to treat injuries that were previously difficult to heal.
Orthopaedics as an example
In orthopaedics, fracture healing fails in approximately 2–10% of cases, corresponding to around 100,000 cases annually in the United States.
This reflects a clear medical need. The orthobiologics market is valued at approximately USD 7 billion and is expected to exceed USD 9 billion by 2031.
Regenerative medicine represents a shift in how we approach treatment, from managing injuries to actively healing them. The combination of significant medical need and rapid technological development makes this an area worth following.
Receive news from Sciety
Sign up for our newsletter to receive news, industry insights, and updates on our investments.
Disclaimer: The information contained in our emails and communications is intended for informational purposes only and is not intended to constitute advice or recommendations on any investment. We do not guarantee the accuracy, completeness, timeliness, or suitability of any information provided. Please note that our communications are not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to local law or regulation. In particular, our communications are not intended for persons in the United States or Australia. We do not accept any liability for any loss or damage arising from the use of our communications, including but not limited to any investment decisions made based on the information provided. Furthermore, please note that any investment in private companies involves a high degree of risk and is not suitable for all investors. Before making any investments, you must read and accept our general terms and conditions for investments, which can be found at the following link: General Terms and Conditions for Investments.
